Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q1JQB3

Entry ID Method Resolution Chain Position Source
AF-Q1JQB3-F1 Predicted AlphaFoldDB

133 variants for Q1JQB3

Variant ID(s) Position Change Description Diseaes Association Provenance
rs481842741 17 H>R No EVA
rs461723844 34 T>P No EVA
rs448383645 36 C>* No EVA
rs479730464 39 L>R No EVA
rs439342926 40 W>* No EVA
rs459550126 40 W>R No EVA
rs477228007 41 A>G No EVA
rs443673301 49 R>P No EVA
rs454750772 50 N>D No EVA
rs441506629 72 L>P No EVA
rs441506629 72 L>R No EVA
rs457061818 104 S>G No EVA
rs436854402 105 I>L No EVA
rs468191759 105 I>T No EVA
rs447937259 111 I>T No EVA
rs479764400 112 S>A No EVA
rs466063424 112 S>W No EVA
rs445921205 113 V>G No EVA
rs477045277 114 D>A No EVA
rs481277413 116 Y>F No EVA
rs443716624 116 Y>H No EVA
rs481277413 116 Y>S No EVA
rs461361456 117 L>P No EVA
rs461361456 117 L>R No EVA
rs441232062 118 A>P No EVA
rs472632403 119 V>G No EVA
rs476814148 120 A>D No EVA
rs439070118 120 A>P No EVA
rs456699953 121 H>P No EVA
rs468226577 123 L>R No EVA
rs454600053 124 R>G No EVA
rs465754137 125 F>S No EVA
rs445910372 126 A>P No EVA
rs469815109 136 A>G No EVA
rs432224825 136 A>T No EVA
rs41639020 144 T>M No EVA
rs481011509 152 P>R No EVA
rs458913766 164 N>K No EVA
rs479082421 164 N>T No EVA
rs439147042 166 T>A No EVA
rs476852673 167 F>L No EVA
rs463158908 169 F>L No EVA
rs443081419 171 K>R No EVA
rs474391856 178 V>G No EVA
rs454568823 180 W>C No EVA
rs434443026 184 Y>S No EVA
rs472198535 185 R>G No EVA
rs452034630 187 F>L No EVA
rs432261235 188 V>E No EVA
rs449892449 197 M>L No EVA
rs467577222 204 I>V No EVA
rs719513044 206 R>Q No EVA
rs479126621 211 S>R No EVA
rs458881682 213 S>P No EVA
rs445211716 216 R>H No EVA
rs483007456 217 Q>P No EVA
rs463296040 219 K>E No EVA
rs474445633 220 V>D No EVA
rs474445633 220 V>G No EVA
rs443120267 220 V>L No EVA
rs440897728 224 R>I No EVA
rs472288645 230 I>N No EVA
rs452084978 232 I>F No EVA
rs432002878 240 Y>S No EVA
rs475994024 241 H>P No EVA
rs456311747 249 A>P No EVA
rs436216895 251 Y>C No EVA
rs467563265 252 L>P No EVA
rs467563265 252 L>R No EVA
rs453842723 253 R>C No EVA
rs483045948 257 D>G No EVA
rs445354606 257 D>Y No EVA
rs469357151 259 G>V No EVA
rs480907005 261 E>G No EVA
rs460710653 262 E>G No EVA
rs440629443 263 R>L No EVA
rs438448002 268 Y>C No EVA
rs476030845 269 H>N No EVA
rs442695393 269 H>Q No EVA
rs455946227 269 H>R No EVA
rs474083153 270 S>C No EVA
rs453928235 270 S>I No EVA
rs453928235 270 S>N No EVA
rs433816664 270 S>R No EVA
rs474083153 270 S>R No EVA
rs453928235 270 S>T No EVA
rs465140367 271 S>P No EVA
rs451857580 271 S>W No EVA
rs469379334 273 A>P No EVA
rs480665018 274 F>S No EVA
rs461078608 275 T>P No EVA
rs447081134 276 S>T No EVA
rs458146462 278 N>K No EVA
rs478489481 278 N>T No EVA
rs438480902 280 V>G No EVA
rs482475989 282 D>A No EVA
rs462389658 282 D>E No EVA
rs482475989 282 D>V No EVA
rs442445425 285 L>R No EVA
rs440278357 286 Y>C No EVA
rs454027441 286 Y>D No EVA
rs440278357 286 Y>S No EVA
rs471607260 287 C>* No EVA
rs451473946 288 L>I No EVA
rs438116086 289 V>L No EVA
rs455753898 290 N>D No EVA
rs466917025 290 N>K No EVA
rs435608866 290 N>S No EVA
rs447154809 294 R>G No EVA
rs464595812 296 D>A No EVA
rs464595812 296 D>G No EVA
rs433445977 296 D>Y No EVA
rs450956016 297 V>G No EVA
rs462528368 298 A>D No EVA
rs482212799 298 A>P No EVA
rs448861657 304 L>P No EVA
rs460064486 316 M>T No EVA
rs480282111 316 M>V No EVA
rs471654259 331 R>M No EVA
rs110769509 332 N>I No EVA
rs444294294 334 M>I No EVA
rs458024273 334 M>R No EVA
rs475581734 338 M>R No EVA
rs455855417 339 A>P No EVA
rs435648873 341 G>D No EVA
rs476398433 343 V>A No EVA
rs476398433 343 V>G No EVA
rs433459339 344 A>E No EVA
rs451092737 347 L>R No EVA
rs468733667 349 Q>K No EVA
rs448984650 353 V>G No EVA
rs480344165 356 K>Q No EVA
rs477794125 362 Q>K No EVA

No associated diseases with Q1JQB3

1 regional properties for Q1JQB3

Type Name Position InterPro Accession
domain GPCR, rhodopsin-like, 7TM 34 - 286 IPR017452

Functions

Description
EC Number
Subcellular Localization
  • Cell membrane ; Multi-pass membrane protein
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

2 GO annotations of cellular component

Name Definition
integral component of plasma membrane The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
plasma membrane The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.

1 GO annotations of molecular function

Name Definition
G protein-coupled receptor activity Combining with an extracellular signal and transmitting the signal across the membrane by activating an associated G-protein; promotes the exchange of GDP for GTP on the alpha subunit of a heterotrimeric G-protein complex.

10 GO annotations of biological process

Name Definition
adenylate cyclase-activating G protein-coupled receptor signaling pathway A G protein-coupled receptor signaling pathway in which the signal is transmitted via the activation of adenylyl cyclase activity and a subsequent increase in the intracellular concentration of cyclic AMP (cAMP).
angiogenesis involved in wound healing Blood vessel formation when new vessels emerge from the proliferation of pre-existing blood vessels and contribute to the series of events that restore integrity to a damaged tissue, following an injury.
glomerular mesangial cell development The process whose specific outcome is the progression of a glomerular mesangial cell in the kidney over time, from its formation to the mature structure.
negative regulation of angiogenesis Any process that stops, prevents, or reduces the frequency, rate or extent of angiogenesis.
positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway Any process that increases the concentration of calcium ions in the cytosol that occurs as part of a PLC-activating G protein-coupled receptor signaling pathway. G-protein-activated PLC hydrolyses phosphatidylinositol-bisphosphate (PIP2) to release diacylglycerol (DAG) and inositol trisphosphate (IP3). IP3 then binds to calcium release channels in the endoplasmic reticulum (ER) to trigger calcium ion release into the cytosol.
positive regulation of inflammatory response Any process that activates or increases the frequency, rate or extent of the inflammatory response.
positive regulation of Rho protein signal transduction Any process that activates or increases the frequency, rate or extent of Rho protein signal transduction.
regulation of cell adhesion Any process that modulates the frequency, rate or extent of attachment of a cell to another cell or to the extracellular matrix.
regulation of vascular permeability Any process that modulates the extent to which blood vessels can be pervaded by fluid.
response to acidic pH Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a pH stimulus with pH < 7. pH is a measure of the acidity or basicity of an aqueous solution.

6 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
O46685 GPR68 Ovarian cancer G-protein coupled receptor 1 Bos taurus (Bovine) PR
P46093 GPR4 G-protein coupled receptor 4 Homo sapiens (Human) PR
Q8BUD0 Gpr4 G-protein coupled receptor 4 Mus musculus (Mouse) PR
Q8BFQ3 Gpr68 Ovarian cancer G-protein coupled receptor 1 Mus musculus (Mouse) PR
P50132 GPR4 G-protein coupled receptor 4 Sus scrofa (Pig) PR
Q4KLH9 Gpr4 G-protein coupled receptor 4 Rattus norvegicus (Rat) PR
10 20 30 40 50 60
MGNRTLEGCH VDSRMDHLFP PSLYIFVIGV GLPTNCLALW AAYRQVRQRN ELGVYLMNLS
70 80 90 100 110 120
IADLLYICTL PLWVDYFLHH DNWIHGPGSC KLFGFIFYTN IYISIAFLCC ISVDRYLAVA
130 140 150 160 170 180
HPLRFARLRR VKTAVAVSSV VWATELGANS APLFHDELFR DRYNHTFCFE KFPMEGWVAW
190 200 210 220 230 240
MNLYRVFVGF LFPWALMLLS YRGILRAVRG SVSTERQEKV KIKRLALSLI AIVLVCFAPY
250 260 270 280 290 300
HVLLLSRSAV YLRRPRDCGF EERVFSAYHS SLAFTSLNCV ADPILYCLVN EGARSDVAKA
310 320 330 340 350 360
LHHLLRFLAS DKPQEMANAS LTLETPLTSK RNSMAKAMAA GWVAAPLAQG DQVQLKMLPP
AQ